Second, aggressive lymphomas with involvement of the central nervous system may benefit from CXCR4-directed PET/CT, as the use of 18F-FDG is hampered by the physiologic biodistribution of 18F-FDG in the central nervous system (65). Here, CXCR4 is linked to lymphoma.